Millions of molecules of lipopolysaccharide (LPS) must be assembled on the Escherichia coli cell surface each time the cell divides. The biogenesis of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane through the periplasm to the cell surface. However, no intermediate transport states have been observed. We developed methods to observe intermediate LPS molecules bound to Lpt proteins in the process of being transported in vivo. Movement of individual LPS molecules along these binding sites required multiple rounds of adenosine triphosphate (ATP) hydrolysis in vitro, which suggests that ATP is used to push a continuous stream of LPS through a transenvelope bridge in discrete steps against a concentration gradient.
Millions of molecules of lipopolysaccharide (LPS) must be assembled on the Escherichia coli cell surface each time the cell divides. The biogenesis of LPS requires seven essential lipopolysaccharide transport (Lpt) proteins to move LPS from the inner membrane through the periplasm to the cell surface. However, no intermediate transport states have been observed. We developed methods to observe intermediate LPS molecules bound to Lpt proteins in the process of being transported in vivo. Movement of individual LPS molecules along these binding sites required multiple rounds of adenosine triphosphate (ATP) hydrolysis in vitro, which suggests that ATP is used to push a continuous stream of LPS through a transenvelope bridge in discrete steps against a concentration gradient.
T he outer membrane of Gram-negative bacteria is an asymmetric bilayer, with the inner leaflet composed of phospholipids and the outer leaflet composed of lipopolysaccharide (LPS). The LPS layer allows Gram-negative bacteria to survive in harsh environments and in the presence of many antibiotics. However, phospholipids and LPS do not spontaneously assemble into an asymmetric bilayer, and the cell devotes substantial resources to synthesizing LPS at the inner membrane and assembling it in the outer membrane (1) . The process by which hydrophobic LPS molecules are transported across two membranes and the intervening aqueous periplasmic space is not understood, but it is known to be mediated by seven essential Lpt (lipopolysaccharide transport) proteins. The heteromeric ATP-binding cassette (ABC) transporter LptBFG forms a complex in the inner membrane with a membrane-bound protein, LptC (Fig. 1A) (2) (3) (4) (5) . Using homologous domains, the C terminus of LptC interacts with the N terminus of LptA, and the C terminus of LptA interacts with the N-terminal periplasmic domain of LptD (6) (7) (8) (9) . The resulting head-to-tail oligomer produced creates a transenvelope protein bridge that connects the inner-membrane Lpt components with the outer-membrane LPS translocon (LptD and LptE) (6, (10) (11) (12) (13) (14) (15) . Defects in any of the Lpt proteins cause LPS to accumulate in the outer leaflet of the inner membrane (2, 16) . However, the mechanism of LPS transport has been difficult to study because it involves two membranes and seemingly cannot be broken into different steps.
To elucidate the mechanism of LPS transport, we first sought to identify sites where LPS interacts with the Lpt proteins in vivo. We incorporated an unnatural amino acid containing a photo-cross-linker ( p-benzoylphenylalanine, pBPA) at 23 positions in LptC and 14 positions in LptA (17) (18) (19) (20) . Four of the LptC mutants and five of the LptA mutants formed cross-links to LPS in an ultraviolet light (UV)-dependent manner (Fig. 1, B and C) . LptC adducts contained the cross-linker at positions 47, 78, 172, and 182 (Fig. 1B) , whereas LptA adducts contained the cross-linker at positions 32, 36, 95, 114, and 116 (Fig. 1C) . Except for residue 47 in LptC, all of these LPS adducts formed on the inside of the b-jellyroll structures. Residue 47 in LptC is in a disordered region of the protein (9), which may become ordered when it interacts with the LptBFG complex or LPS. No cross-links from side chains on the outer surface of the b jellyroll of LptC or LptA were observed. Thus, we propose that LPS specifically binds inside these proteins and transits the periplasm on the inside of the b jellyroll of these proteins.
To determine whether LptC or LptA alone can extract LPS from the inner membrane or whether cross-linking to LPS is dependent on the entire transenvelope complex, we manipulated the expression levels of the Lpt components. We overexpressed LptC or LptA alone or in combination with the other inner-membrane Lpt proteins (i.e., LptBFG or LptBFGC), reasoning that LptC and LptA would mostly not reside in Lpt complexes if they were overexpressed individually. Cross-linking of LPS to LptC at position 47, but not at positions 78, 172, or 182, increased substantially when LptBFG was co-overexpressed ( Fig. 2A) . Thus, when LptA, LptD, and LptE are limiting, LPS accumulates near residue 47 of LptC. Position 47 may be located near a strong binding site for LPS, whereas the other cross-linking positions may reflect more transient interactions that occur during the movement of LPS through fully assembled bridges. Because LPS accumulation at the binding site around residue 47 depends on LptBFG, it is also clear that LptC cannot extract LPS directly from the inner membrane unaided.
All five LptA mutants showed increased cross-linking with LPS when they were cooverexpressed with LptBFGC (Fig. 2B) . Thus, LptA cannot receive LPS directly from the inner membrane, but requires LptBFGC complex. LPS must migrate out of the inner membrane in an ordered process that requires LptBFG to get to LptC and LptBFGC to get to LptA. Because LPS transport between these proteins can occur in incomplete Lpt bridges, it was possible to develop a biochemical system to separate the individual step of LPS release from the membrane from that of the transport step along the Lpt bridge.
To study the ATP dependence of LPS extraction from the inner membrane, we first prepared spheroplasts containing overexpressed LptC(T47pBPA) and LptBFG by disrupting the outer membrane and cell wall with ethylenediaminetetraacetic acid (EDTA) and lysozyme. The inner membrane was then permeabilized by osmotic shock to introduce buffer with or without ATP into the cytoplasm to generate rightside-out (RSO) membrane vesicles (21) (22) (23) (24) (25) . These vesicles were then irradiated with UV light. Substantial LPS cross-linking to residue 47 of LptC was only observed when LptBFG was cooverexpressed and ATP was present (Fig. 3A) . A small amount of LPS was cross-linked to LptC in the absence of ATP, but this amount did not increase over time (Fig. 3A) . Presumably this small amount of LPS was present before generating the RSO fraction. Because cross-linking increased as a function of time in the presence of ATP, transfer of LPS from the inner membrane to the membrane-bound LptC appears to require energy.
We next addressed whether LPS could be transferred to the periplasmic component, LptA, in this in vitro system. This reconstitution requires release of LPS from a membrane fraction to a soluble periplasmic protein ( fig. S1 ). Purified LptA(I36pBPA), which cross-linked LPS in vivo, was added to RSO vesicles and analyzed for cross-linking to LPS. LPS cross-linked to LptA over time only in the presence of ATP and when all four inner-membrane components were overexpressed (Fig. 3B) . Notably, LPS did not cross-link to LptA in the absence of LptC overexpression; this finding indicates that LPS must first be transferred to LptC before being transferred to LptA, which is consistent with previous work (9) .
To confirm that the soluble periplasmic bridge component assembled in this in vitro system reflects the in vivo assembly process, we tested the specificity of this cross-linking. An LptA mutant, LptA(H37pBPA), interacts directly with LptC (6) but not with LPS in vivo (Fig. 1C) . Residues Ile 36 and His 37 are both located on the edge of the b jellyroll that interacts with LptC, but their side chains are oriented in opposite directions (Fig. 3C) . In this RSO vesicle reconstitution, the His 37 mutant cross-linked to LptC (Fig.  3D) . However, although His 37 is directly adjacent to Ile 36 , His 37 did not cross-link to LPS in the presence of ATP (Fig. 3B) . Thus, our in vitro reconstitution cleanly recapitulates the specific protein-protein and the protein-substrate interactions observed in vivo. Because the binding of LptA to LptC was rapid and did not depend on time or the presence of ATP (Fig. 3D) , energy appears not to be required for assembly of the bridge, but is required to transport LPS from the inner membrane to LptA.
A small amount of LPS accumulated in LptC in the absence of ATP (Fig. 3A) but did not spontaneously move to LptA (Fig. 3B) . We thus asked whether LPS transfer from LptC to LptA requires a separate energetic step. We incubated RSO vesicles overexpressing LptBFG-LptC(T47pBPA) with ATP to accumulate LPS in LptC, and then added purified LptA(I36pBPA) with or without an adenosine triphosphatase (ATPase) inhibitor, vanadate, before irradiating the samples. LPS did not cross-link to LptA in the inhibitortreated samples, which shows that LPS transfer from LptC to LptA required energy (Fig. 4A) . In the absence of vanadate, LptC-cross-linked adducts with LPS were not decreased even when LPS transferred to LptA, which suggests that the binding sites for LPS in the periplasmic bridge are always filled with LPS during its transport. Thus, at least two energy-dependent steps are involved in LPS transport: one during extraction from the membrane to the periplasmic domain of the membranebound LptC, and another during transfer of LPS In His-tagged LptC, eight residues on the inner surface, 11 residues on the outer surface, and four residues in the disordered region (shown as a dashed line) were mutated to incorporate pBPA. Four positions (red), three on the inner surface and one in the disordered region, cross-linked to LPS upon UV irradiation. Cross-linking adducts (LPS × LptC) were detected by nickel affinity chromatography followed by immunoblotting with antibodies to LPS (WT, wild type). Non-cross-linked LPS was also detected. Single-letter amino acid abbreviations: A, Ala; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; N, Asn; P, Pro; Q, Gln; S, Ser; T, Thr; V, Val; Y, Tyr. (C) Specific amino acid positions in LptA cross-linked to LPS. As in (B), six and eight positions on the inner and outer surfaces, respectively, of the b jellyroll were mutated to pBPA and evaluated after UV irradiation by immunoblotting. Five specific positions (red) on the inner surface of LptA cross-linked to LPS.
www.sciencemag.org SCIENCE VOL 338 30 NOVEMBER 2012 from LptC to LptA. These steps may occur synchronously. We propose a model for LPS transport in which ATP hydrolysis in the cytoplasm provides energy to push LPS molecules in discrete steps across the bridge (Fig. 4B) .
The mechanism of LPS transport is somewhat similar to that of efflux pumps, which also form transenvelope bridges and use energy to drive a small molecule through a continuous channel to the exterior environment (26) (27) (28) . The model for efflux pumps suggests that only one energydependent step drives one toxic molecule out of the cell. This requirement reflects the fact the noxious molecules are released from the internal three-dimensional reservoir into the channel of the pump, which is continuous with the infinite exterior environment; diffusion can efficiently carry the molecule away. Movement of LPS from the inner membrane to the outer membrane across the periplasm proceeds through a series of energy-dependent steps as sequential molecules are pushed in a continuous stream through the bridge. The problem of LPS transport is different from drug efflux in that LPS must move from a two-dimensional reservoir at the inner membrane to another two-dimensional reservoir at the cell surface in opposition to the concentration gradient. Multiple rounds of ATP hydrolysis are required to increase the efficiency of unidirectional transport. If transport across the periplasmic bridge requires that multiple binding sites on Lpt proteins be filled with LPS during transport, it may be possible to design inhibitors that destroy the pumping mechanism by introducing air in the line. 
